368A
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Kitazato Corporation is a medical device and reagent manufacturer specializing in reproductive engineering technologies for assisted reproduction, including artificial insemination and in vitro fertilization. The company develops and produces products for the entire IVF workflow, covering oocyte and sperm collection, washing, fertilization, culture, and cryopreservation. Key products include the Cryotop and Cryotop-CL cryovials, Ova Cryo Sheet, ET catheters, IUI catheters, OPU needles, and various media and reagents such as HTF medium and vitrification solutions. The group operates through subsidiaries Kitazato BioScience, Kitazato Testing Center, Kitazato Healthcare, and Kitazato Cryobank, with Kitazato America, Inc. handling distribution and regulatory affairs in the United States. Kitazato supplies hospitals and clinics in Japan and globally via a network of distributors. The company manufactures all products in Japan, utilizing manual craftsmanship to produce customized micro-tools and glass pipettes for ICSI and assisted hatching. It collaborates with universities and clinics worldwide for joint research and development, particularly in ultra-rapid vitrification technology.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Medical Devices Homepage kitazato.co.jp
Sector Healthcare IR page kitazato.co.jp/en
Tags
reproductive medicine, in vitro fertilization, cryopreservation, assisted reproduction, medical reagents, glass pipettes, catheters, vitrification, icsi, fertility treatment, Kitazato BioScience, Kitazato Testing Center, Kitazato Healthcare, Kitazato Cryobank, Kitazato America Inc., Cryotop, Cryotop-CL, Ova Cryo Sheet, ET catheter, IUI catheter, OPU needle, ICSI Injection Pipette, ICSI Holding Pipette, PZD Needle, HTF medium, Biomedical Supply S.L., Biomedical Supply US Inc.
Press page —

Metrics

Valuation  
Market cap ¥ 57.08B
Market cap (USD) $ 356.754M
P/E 13.86
PEG 2.80
P/BV 2.73
P/S 4.88
P/OCF 13.58
P/FCF 14.24
Dividend yield 2.9%
Turnover / mcap —
Returns  
ROE 20.1%
ROI 19.0%
ROIC 18.8%
Profit margin 35.6%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 4.9%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 27.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue 10.947B 10.302B 10.08B 9.348B 8.14B 6.766B
Net profit 3.895B 3.788B 3.972B 3.37B 2.952B 2.354B
Free cash flow 3.631B 2.623B 4.415B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Share price 1.315K — — — — —
P/FCF 14.48 — — — — —

Filed figures

Figure Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 1.19B 1.46B 1.56B
↳ YoY growth +22.9% +7.0%
Cash and deposits (JPY) 10.5B 11.5B 13.4B
Intangible assets (JPY) 78M 61M 47M
Cash flow detail
Operating cash flow (JPY) 4.5B 3.53B 3.87B
Purchases of property, plant and equipment (JPY) -76M -899M -239M
Purchases of intangible assets (JPY) -9M -4M —
Change in receivables (cash effect) (JPY) 320M -271M -102M
Change in inventories (cash effect) (JPY) -262M 173M -209M
Change in payables (cash effect) (JPY) -32M 116M -64M
Dividends paid (cash effect) (JPY) -2B -1.6B -1.64B
Interest paid (cash effect) (JPY) -1M -1M -1M
Income taxes paid (cash effect) (JPY) -1.74B -2.26B -1.87B
Operating cash flow before change in receivables (JPY) 4.18B 3.8B 3.97B
Free cash flow (OCF - PPE - intangibles) (JPY) 4.42B 2.62B 3.63B
Income detail
Research and development expense (JPY) 8M 3M 14M
Total comprehensive income (JPY) 3.97B 3.79B 3.9B
Comprehensive income to owners (JPY) 3.97B 3.79B 3.9B
Reported Jun 30, 2025 Jun 30, 2025 Jun 24, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

臨時報告書(第19条第2項第3号) Bull 0 Bear 0 Routine
子会社の設立に関するお知らせ Bull 1 Bear 0 Routine

Prompts

Kitazato Corporation (ticker 368A), listed in Japan.

ETFs Holding Kitazato Corporation

ETF Weight in ETF Shares Market value As of
AVSD 0.00% 1,500 $ 11.924K Nov 16, 2026
AVDS 0.00% 1,500 $ 11.924K Nov 16, 2026